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FIRST PERSON
First person – Laura Kuil and Nynke Oosterhof
First Person is a series of interviewswith the first authors of a selection of
papers published in Disease Models & Mechanisms (DMM), helping
early-career researchers promote themselves alongside their papers.
Laura Kuil andNynkeOosterhof are co-first authors on ‘Reverse genetic
screen reveals that Il34 facilitates yolk sac macrophage distribution and
seedingof thebrain’, published inDMM.Laura is aPhDstudent in the lab
ofDr TjakkovanHamatErasmusUniversityMedicalCenter,Rotterdam,
The Netherlands, investigating the genetic regulation of microglia/
macrophage development and their function. Nynke is a postdoc in the
lab of Dr Judith Paridaen at University Medical Center Groningen,
Groningen, The Netherlands, investigating cortical neurogenesis.
How would you explain the main findings of your paper
to non-scientific family and friends?
LK: Microglia are the immune cells of the brain and are involved in
many brain diseases (e.g. Alzheimer’s disease). In the healthy brain,
microglia are quite busy cells that remodel connections between cells,
clean all types of waste material and support the formation of myelin.
Microglia develop from progenitor cells that arise on the yolk sac
macrophages (YSMs), which migrate towards the brain during
embryonic development. How their development is regulated remains
largely undiscovered. Therefore, we developed a strategy to switch
off genes one by one, and identify genes that affect the early
development of microglia in a living organism, the zebrafish. We
found that a signaling molecule, called Il34, facilitates the migration
of YSMs towards the brain and other tissues. These findings bring us
one step closer to understanding what regulates the journey of
microglia progenitor cells to the brain during development, which is
important for the therapeutic potential of microglia and, for example,
the replacement of defective microglia in the diseased brain.
NO: I would start to say that the brain consists of different types of
cells, including microglia, which are the cells that are important for
the development and protection of our brains. In fact, mistakes in
genes that, in the brain, appear to be specifically expressed in
microglia have been identified as causes for severe brain diseases as
well as brain malformations. During early embryonic development,
microglia precursors develop on the yolk sac, after which they travel
to the brain to become microglia. However, the exact genes and
mechanisms involved in the development of microglia are still not
completely known and understood. In this study, we used zebrafish
to perform a small-scale genetic screen to identify genes that are
important for the development of microglia. In this screen, we tested
20 genes and identified a gene called il34 as a regulator of microglia
development. Additional experiments revealed that this gene, which
encodes a signaling molecule, is necessary for microglia precursor
cells to find their way to the brain.
What are the potential implications of these results for your
field of research?
LK and NO: In this study, we showed that we were able to
successfully identify genes that are important for microglia
development with our reverse genetic screening method in
zebrafish. We tested only 20 genes; however, it is possible to
increase the throughput of this screening method. This would allow
for a relatively rapid way to identify new regulators of microglia
development. This would be particularly interesting in the context of
brain diseases with potential/certain microglia involvement. In
addition, microglia are very difficult to culture, as their phenotype
highly depends on their environment. Because of this, they lose their
brain-specific properties as soon as they are taken into a cell culture
environment. Insight into their developmental regulation could help
with the development of better culturing protocols, as well as assist
in, for example, the development of induced pluripotent stem cell-
derived microglia and their delivery to the brain. Our small-scale
screen identified Il34 as an important regulator of microglia
development. The role of Il34 in early microglia development was,
based on previous studies, controversial. Our findings show direct
evidence for a role of Il34 in early microglia development.
“What surprised me is the high efficiency
of gene targeting we could reach in
injected zebrafish by using CRISPR/Cas9
complex injections.”
What are the main advantages and drawbacks of the model
system you have used as it relates to the disease you are
investigating?
NO and LK: The main reason for using zebrafish in this study is that
with CRISPR/Cas9-based genome editing it is possible to get a very
high throughput in a relatively short amount of time compared to
mammalian model organisms. In zebrafish, the first microglia have
appeared and started to colonize the brain within 3 days after
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fertilization. Also, the embryos are transparent and can easily take up
chemicals including dyes from the water, which allowed us to label
microglia and determine their numbers several days after fertilization
in live embryos. Additionally, they have a high fecundity and often
lay >100 fertilized eggs per breeding pair. Finally, mutagenesis
by CRISPR/Cas9-based genome editing works so efficiently that
mutant phenotypes can be created directly in injected animals. A
drawback of this model system could be that, evolutionarily
speaking, zebrafish are not as closely related to humans as
mammals. However, given that many tissues, cell types and genes
are conserved between zebrafish and mammals, there is a high
chance that genes that are important for microglia development in the
zebrafish also play a role in mammalian microglia development.
What has surprised you the most while conducting
your research?
NO: At the moment, I can’t think of anything that really surprised
me during my research. One of the things I really liked though was
that for the development of our SpotNGlia software tool we worked
together with people with completely different backgrounds, such
as physics. I thought it was really interesting to see howwe looked at
our research question from a completely different point of view.
I think this experience was very valuable and really helped me to
look at problems from different perspectives.
LK:What surprised mewas the high efficiency of gene targeting we
could reach in injected zebrafish by using CRISPR/Cas9 complex
injections. This enabled us to directly analyze ‘crispants’ within a
workweek, which nicely speeds up the process of identifying genes
affecting – in this case –microglia, but this is applicable to countless
cell types and disease-related questions.
Describe what you think is the most significant challenge
impacting your research at this time and how will this be
addressed over the next 10 years?
LK: With respect to availability of, for example, antibodies and
conditional knockout approaches, I think the zebrafish field
(but also that of other genetic models such as C. elegans and
Drosophila) is still catching up with the mouse field. Within the
next 10 years, I think this will dramatically change, especially
with the success of applying genome editing using CRISPR/
Cas9 and other or modified versions, to generate patient-specific
mutations and reporter lines in zebrafish.
NO: I think that the focus will be more and more on things that
happen at the single-cell level. Even though, with in vivo imaging
studies (for which the zebrafish is an ideal model organism), it is
possible to study cell behavior at the single-cell level, it would be very
useful if this could be directly related to cellular heterogeneity
identified by single-cell omics techniques. Some techniques have
already been developed that allow for real-time visualization of
transcription and I think these kinds of imaging techniques will be
more widely used and further developed in the coming years.
“[…] it is always a good idea for a PhD
student to have a back-up plan, in terms of
side projects, in case your ‘main’ project
does not go as planned.”
What changes do you think could improve the professional
lives of early-career scientists?
NO: I think this is a very difficult question. I could say things like
more funding and opportunities, but I am not really sure whether this
is all that is important. I also think that there are things that we as
early-career scientists can do ourselves. For example, I think that,
in the coming years, bioinformatics will become more and more
important in biological research and that, as a biologist, having some
bioinformatic skills will become a necessity. Therefore, I think that
trying to get that kind of knowledge, for example, through courses or
by talking to people with the necessary expertise will be important.
LK: In my opinion, increased possibilities for early-career scientists to
give oral presentations at conferences and more funding possibilities
for ‘high risk-high gain’ projects for young scientists would improve
their professional lives. From my own experience I can say that it is
always a good idea for a PhD student to have a back-up plan, in terms
of side projects, in case your ‘main’ project does not go as planned.
What’s next for you?
LK: I will soon defend my PhD thesis and after that start a
new challenge, perhaps a nice postdoc positionworkingwith zebrafish.
NO: After defending my thesis last year, I started as a postdoc on a
project in which I will try to gain more insight into the mechanisms
involved in cortical neurogenesis.
What where the most fun activities you did with your
labmates?
LK: One of our current students is very good at a form of rock
climbing called ‘bouldering’, so we went bouldering with all our
group members and she taught us how to do it – it was so much fun!
NO and LK: Escape rooms!
Reference
Kuil, L. E., Oosterhof, N., Geurts, S. N., van der Linde, H. C., Meijering, E. and
van Ham, T. J. (2019). Reverse genetic screen reveals that Il34 facilitates yolk sac
macrophage distribution and seeding of the brain. Dis. Model. Mech. 12,
dmm037762.
Images of zebrafish larvae stained with Neutral Red, which labels the
microglia used in the reverse genetic screen.
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